» Articles » PMID: 18494050

Diagnosis and Initial Management of Cholangiocarcinoma with Obstructive Jaundice

Overview
Specialty Gastroenterology
Date 2008 May 22
PMID 18494050
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Cholangiocarcinoma is the second most common primary hepatic cancer. Despite advances in diagnostic techniques during the past decade, cholangiocarcinoma is usually encountered at an advanced stage. In this review, we describe the classification, diagnosis, and initial management of cholangiocarcinoma with obstructive jaundice.

Citing Articles

A Complex Case of Obstructive Jaundice in a Septuagenarian: Diagnostic Challenges and Therapeutic Strategies.

Anwar S, Rasool Malik A, Hamza A, Shahid M, Subhan M, Bibi R Cureus. 2024; 16(7):e64598.

PMID: 39149640 PMC: 11325256. DOI: 10.7759/cureus.64598.


Prognostic Nomogram That Predicts Overall Survival of Patients with Distal Cholangiocarcinoma After Pancreatoduodenectomy.

Chen Q, Li J, Jin B, Wu X, Shi Y, Xu H Cancer Manag Res. 2020; 12:10303-10310.

PMID: 33116885 PMC: 7585820. DOI: 10.2147/CMAR.S276393.


Reversal of jaundice in two patients with inoperable cholangiocarcinoma treated with Cisplatin and gemcitabine combination.

Criel M, Geurs F, Ponette S, Bulte K, Ponette J Case Reports Hepatol. 2015; 2012:138381.

PMID: 25954551 PMC: 4412096. DOI: 10.1155/2012/138381.


Infection with the carcinogenic liver fluke Opisthorchis viverrini modifies intestinal and biliary microbiome.

Plieskatt J, Deenonpoe R, Mulvenna J, Krause L, Sripa B, Bethony J FASEB J. 2013; 27(11):4572-84.

PMID: 23925654 PMC: 3804743. DOI: 10.1096/fj.13-232751.


Real-time PCR-based analysis of the human bile microRNAome identifies miR-9 as a potential diagnostic biomarker for biliary tract cancer.

Shigehara K, Yokomuro S, Ishibashi O, Mizuguchi Y, Arima Y, Kawahigashi Y PLoS One. 2011; 6(8):e23584.

PMID: 21858175 PMC: 3157401. DOI: 10.1371/journal.pone.0023584.


References
1.
Martin 2nd R, Vitale G, Reed D, Larson G, Edwards M, McMasters K . Cost comparison of endoscopic stenting vs surgical treatment for unresectable cholangiocarcinoma. Surg Endosc. 2002; 16(4):667-70. DOI: 10.1007/s004640080006. View

2.
Smits N, Reeders J . Imaging and staging of biliopancreatic malignancy: role of ultrasound. Ann Oncol. 1999; 10 Suppl 4:20-4. View

3.
Bowling T, Galbraith S, Hatfield A, Solano J, Spittle M . A retrospective comparison of endoscopic stenting alone with stenting and radiotherapy in non-resectable cholangiocarcinoma. Gut. 1996; 39(6):852-5. PMC: 1383458. DOI: 10.1136/gut.39.6.852. View

4.
Coons H, Carey P . Large-bore, long biliary endoprostheses (biliary stents) for improved drainage. Radiology. 1983; 148(1):89-94. DOI: 10.1148/radiology.148.1.6304813. View

5.
Maguchi H, Takahashi K, Katanuma A, Osanai M, Nakahara K, Matuzaki S . Preoperative biliary drainage for hilar cholangiocarcinoma. J Hepatobiliary Pancreat Surg. 2007; 14(5):441-6. DOI: 10.1007/s00534-006-1192-3. View